Haraldsplass Deaconess Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease3 trials

Phase

• Phase 23 trials

Status

• Completed1 trial
• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• Haukeland University Hospital2 trials
• Helse Stavanger HF1 trial

Running trials

• Recruiting

  N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease

  NCT07741071· Phase 2· Haukeland University Hospital· Source

  Contact: Lone B Johansen

• Recruiting

  Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)

  NCT06362707· Phase 2· Helse Stavanger HF· Source

  Contact: Dag Aarsland, PhD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting

Closed trials

• Completed

  N-DOSE AD: A Dose Optimization Trial of Nicotinamide Riboside in Alzheimer's Disease

  NCT05617508· Phase 2· Haukeland University Hospital· Source